These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12218617)

  • 1. Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study.
    Ogawa K; Takei S; Inoue Y; Kanzaki J
    Otol Neurotol; 2002 Sep; 23(5):665-8. PubMed ID: 12218617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of lipoprostaglandin E1 on sudden hearing loss.
    Ahn JH; Kim MR; Kim HC
    Am J Otolaryngol; 2005; 26(4):245-8. PubMed ID: 15991090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
    Westerlaken BO; de Kleine E; van der Laan B; Albers F
    Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E1 effects on CD62p and PAC-1 in patients with sudden sensorineural hearing loss.
    Xi J; Liu H; Wang X
    Thromb Res; 2020 Apr; 188():31-38. PubMed ID: 32044505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial.
    Westerlaken BO; Stokroos RJ; Dhooge IJ; Wit HP; Albers FW
    Ann Otol Rhinol Laryngol; 2003 Nov; 112(11):993-1000. PubMed ID: 14653370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of systemic and intratympanic corticosteroid combination therapy versus intratympanic or systemic therapy in patients with idiopathic sudden sensorineural hearing loss: a randomized controlled trial.
    Ashtiani MK; Firouzi F; Bastaninejad S; Dabiri S; Nasirmohtaram S; Saeedi N; Ghazavi H; Sahebi L
    Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):89-97. PubMed ID: 29149379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for profound sudden idiopathic sensorineural hearing loss: a multicenter retrospective study.
    Lee HY; Kim DK; Park YH; Cha WW; Kim GJ; Lee SH
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):143-149. PubMed ID: 27544193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transtympanic steroids in refractory sudden hearing loss. Personal experience.
    Dallan I; Bruschini L; Nacci A; Fattorp B; Traino AC; Rognini F; Ferraro G; Bruschini P
    Acta Otorhinolaryngol Ital; 2006 Feb; 26(1):14-9. PubMed ID: 18383752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
    Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1 in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.
    Suzuki H; Fujimura T; Ikeda K; Shiomori T; Udaka T; Ohbuchi T; Nagatani G
    Acta Otolaryngol; 2008 Jan; 128(1):61-5. PubMed ID: 17851957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial.
    Koo JW; Chang MY; Yun SC; Kim TS; Kong SK; Chung JW; Goh EK
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2433-41. PubMed ID: 26559533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral treatment of idiopathic sudden sensorineural hearing loss: a prospective, randomized, double-blind clinical trial.
    Stokroos RJ; Albers FW; Tenvergert EM
    Acta Otolaryngol; 1998 Jul; 118(4):488-95. PubMed ID: 9726671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP; Chou YF; Yu SH; Wang CP; Hsu CJ; Chen PR
    Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipo-prostaglandin E1 in combination with steroid therapy is effective for treatment of sudden sensorineural hearing loss in Korean patients with Type 2 diabetes.
    Ahn JH; Kim TY; Kim YJ; Han MW; Yoon TH; Chung JW
    Diabet Med; 2006 Dec; 23(12):1339-43. PubMed ID: 17116185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravenous administration of prostaglandin E(1) and lipo-prostaglandin E(1) on cochlear blood flow in guinea pigs.
    Nishimura T; Nario K; Hosoi H
    Eur Arch Otorhinolaryngol; 2002 May; 259(5):253-6. PubMed ID: 12107528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss.
    Agarwal L; Pothier DD
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD003422. PubMed ID: 19821308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 versus steroid in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.
    Suzuki H; Fujimura T; Shiomori T; Ohbuchi T; Kitamura T; Hashida K; Udaka T
    Auris Nasus Larynx; 2008 Jun; 35(2):192-7. PubMed ID: 17826927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.
    Gouveris H; Selivanova O; Mann W
    Eur Arch Otorhinolaryngol; 2005 Feb; 262(2):131-4. PubMed ID: 15747106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.